1-24331573-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198173.3(GRHL3):āc.165C>Gā(p.Asp55Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 1,613,514 control chromosomes in the GnomAD database, including 23,185 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_198173.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRHL3 | NM_198173.3 | c.165C>G | p.Asp55Glu | missense_variant | 2/16 | ENST00000361548.9 | NP_937816.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRHL3 | ENST00000361548.9 | c.165C>G | p.Asp55Glu | missense_variant | 2/16 | 1 | NM_198173.3 | ENSP00000354943 | P1 |
Frequencies
GnomAD3 genomes AF: 0.170 AC: 25869AN: 152002Hom.: 2314 Cov.: 32
GnomAD3 exomes AF: 0.158 AC: 39675AN: 251202Hom.: 3333 AF XY: 0.155 AC XY: 21071AN XY: 135782
GnomAD4 exome AF: 0.167 AC: 243937AN: 1461394Hom.: 20866 Cov.: 32 AF XY: 0.165 AC XY: 120267AN XY: 727028
GnomAD4 genome AF: 0.170 AC: 25883AN: 152120Hom.: 2319 Cov.: 32 AF XY: 0.166 AC XY: 12371AN XY: 74370
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 18, 2020 | This variant is associated with the following publications: (PMID: 31332962) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 08, 2021 | The p.Asp55Glu variant in GRHL3 is classified as benign because it has been identified in 15.97% (4526/282536) of total chromosomes in gnomAD, including 3777 homozygous individuals (http://gnomad.broadinstitute.org). ACMG/AMP criteria applied: BA1. - |
Van der Woude syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at